Genetic immunotherapy of established tumors with adenovirus-murine granulocyte-macrophage colony-stimulating factor

Human Gene Therapy

Volumn 8, Issue 2, 1997, Pages 187-193

  Lee, Choon Taek ^a,b   Wu, Shan ^a   Ciernik, I Frank ^a   Chen, Hailei ^a,c   Nadaf Rahrov, Sorena ^a   Gabrilovich, Dmitry ^a   Carbone, David P ^a  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b Korea Cancer Center Hospital   (South Korea)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; EXPRESSION VECTOR; FEMALE; GENE THERAPY; GENETIC TRANSDUCTION; LEWIS CARCINOMA; LUNG CANCER; MOUSE; NONHUMAN; VIRUS RECOMBINANT;

EID: 0031046583     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.2-187     Document Type: Article

References (27)

1. ARMSTRONG, C.A., BOTELLA, R., GALLOWAY, T.H., MURRAY, N., KRAMP, J.M., SONG, S.I., and ANSEL, J.C. (1996). Antitumor effects of granulocyte-macrophage colony-stimulating factor production by melanoma cells. Cancer Res. 56, 2191-2198.
2. BECKER, T.C., NOEL, R.J., COATS, W.S., GOMEZ-FOIX, A.M., ALAM, T., GERARD, R.D., and NEWGAARD, C.B. (1994). Use of recombinant adenovirus for metabolic engineering of mammalian cells. Protein expression in animal cells. Methods Cell Biol. 43, 161-188.
3. BERKNER, K.L. (1988). Development of adenovirus vectors for the expression of heterologous genes. Biotechniques. 6, 616-629.
4. BUBENIK, J., VOITENOK, N.N., KIELER, J., PRASSOLOV, V.S., CHUMAKOV, P.M., BUBENIKOVA, D., SIMOVA, J., and JANDLOVA, T. (1988). Local administration of cells containing an inserted Il-2 gene and producing Il-2 inhibits growth of human tumors in Nu/Nu mice. Immunol. Lett. 19, 279-282.
5. COLOMBO, M.P., FERRARI, G., STOPPACCIARO, A., PARENZA, M., RODOLFO, M., MAVILIO, F., and PARMIANI, G. (1991). Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo. J. Exp. Med. 173, 889-897.
6. DRANOFF, G., JAFFEE, E., LAZENBY, A., GOLUMBEK, P., LEVITSKY, H., BROSE, K., JACKSON, V., HAMADA, H., PARDOLL, D., and MULLIGAN, R.C. (1993). Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA 90, 3539-3543.
7. GABRILOVICH, D.I., CIERNIK, I.F., and CARBONE, D.P. (1996a). Dendritic cells in antitumor immune responses. I. Defective antigen presentation in tumor-bearing hosts. Cell. Immunol. 170, 101-110.
8. GABRILOVICH, D.I., NADAF, S., CORAK, J., BERZOFSKY, J.A., and CARBONE, D.P. (1996b). Dendritic cells in anti-tumor immune responses. II. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice are effective antigen carriers in the therapy of established tumors. Cell. Immunol. 170, 111-119.
9. GANSBACHER, B., BANNERJI, R., DANIELS, B., ZIER, K., CRONIN, K., and GILBOA, E. (1990). Retroviral vector-mediated gamma-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity. Cancer Res. 50, 7820-7825.
10. GOLUMBEK, P.T., AZHARI, R., JAFFEE, E.M., LEVITSKY, H.I., LAZENBY, A., LEONG, K., and PARDOLL, D.M. (1993). Controlled release, biodegradable cytokine depots: a new approach in cancer vaccine design. Cancer Res. 53, 5841-5844.
11. GRAHAM, F.L., and PREVEC, L. (1991). Manipulation of adenovirus vectors. Gene transfer and expression protocols. In Methods in Molecular Biology. E. Murray, ed. (Humana Press, Inc., Clifton, NJ) pp. 109-128.
12. HAN, S.K., BRODY, S.L., and CRYSTAL, R.G. (1994). Suppression of in vivo tumorigenicity of human lung cancer cells by retrovirus-mediated transfer of the human tumor necrosis factor-alpha cDNA. Am. J. Respir. Cell. Mol. Biol. 11, 270-278.
13. INABA, K., INABA, M., ROMANI, N., AYA, H., DEGUCHI, M., IKEHARA, S., MURAMATSU, S., and STEINMAN, R.M. (1992). Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176, 1693-1702.
14. JAFFEE, E.M., and PARDOLL, D.M. (1995). Gene therapy: its potential applications in the treatment of renal-cell carcinoma. Semin. Oncol. 22, 81-91.
15. KEDAR, E., and KLEIN, E. (1992). Cancer Immunotherapy: Are the results discouraging? Can they be improved? Adv. Cancer Res. 59, 245-322.
16. KOZAK, M. (1981). Possible role of flanking nucleotides in recognition of the AUG initiator codon by eukaryotic ribosomes. Nucleic Acids Res. 9, 5233-5262,
17. KRUH, J. (1982). Effects of sodium butyrate, a new pharmacological agent, on cells in culture. Mol. Cell. Biochem. 42, 65-82.
18. LEE, C.-T., CHEN, H.L., and CARBONE, D.P. (1995). Gene therapy for lung cancer. Ann. Oncol. 6, 61-63.
19. LEVITSKY, H.I., LAZENBY, A., HAYASHI, R.J., and PARDOLL, D.M. (1994). In vivo priming of two distinct antitumor effector populations: the role of MHC class I expression. J. Exp. Med. 179, 1215-1224.
20. MCBRIDE, W.H., THACKER, J.D., COMORA, S., ECONOMOU, J.S., KELLEY, D., HOGGE, D., DUBINETT, S.M., and DOUGHERTY, G.J. (1992). Genetic modification of a murine fibrosarcoma to produce interleukin 7 stimulates host cell infiltration and tumor immunity. Cancer Res. 52, 3931-3937.
21. PORGADOR, A., TZEHOVAL, E., KATZ, A., VADAI, E., REVEL, M., FELDMAN, M., and EISENBACH, L. (1992). Interleukin 6 gene transfection into Lewis lung carcinoma tumor cells suppresses the malignant phenotype and confers immunotherapeutic competence against parental metastatic cells. Cancer Res. 52, 3679-3686.
22. ROSENBERG, S.A. (1988). Immunotherapy of cancer using interleukin 2: Current status and future prospects. Immunol. Today 9, 58-62.
23. ROTH, C., ROCHLITZ, C., and KOURILSKY, P. (1994). Immune response against tumors. Adv. Immunol. 57, 281-351.
24. TANG, D.C., and TAYLOR, M.W. (1990). Transcriptional activation of the adenine phosphoribosyltransferase promoter by an upstream butyrate-induced Moloney murine sarcoma virus enhancer-promoter element. J. Virol. 64, 2907-2911.
25. TANG, D.C., and TAYLOR, M.W. (1992). Memory of butyrate induction by the Moloney murine sarcoma virus enhancer-promoter element. Biochem. Biophys. Res. Commun. 189, 141-147.
26. TANG, D-C, JOHNSTON, S.A., and CARBONE, D.P. (1994). Tumor-restricted gene expression by adenovirus-mediated gene transfer. Cancer Gene Ther. 1, 15-20.
27. TEPPER, R.I., PATTENGALE, P.K., and LEDER, P. (1989). Murine interleukin-4 displays potent anti-tumor activity in vivo. Cell 57, 503-512.